Marcus A. Conant
Corporate Officer/Principal en The University of California, San Francisco .
Perfil
Marcus A.
Conant is Chief Medical Officer of Presidio Pharmaceuticals, Inc., a Clinical Professor at the University of California, San Francisco, and Chairman of the Conant Foundation.
He was a Director of Enzo Biochem, Inc. Dr. Conant has 25 years of experience in treating HIV/AIDS patients.
He received a BS degree and an MD from Duke University.
Cargos activos de Marcus A. Conant
| Empresas | Cargo | Inicio |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Marcus A. Conant.
| Empresas | Cargo | Fin |
|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Director Técnico/Científico/I+D | - |
| ENZO BIOCHEM, INC. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Marcus A. Conant